# OnCo record avantect-mcd (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/avantect-mcd/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "avantect-mcd" ;
  schema:name "Avantect Multi-Cancer Detection Test"@en ;
  schema:alternateName "Avantect MCD"@en, "Avantect multi-cancer"@en, "Avantect" ;
  schema:description "ClearNote Health's blood test for several cancers, one of the two tests in the US National Cancer Institute's randomised Vanguard study, with no published performance figures yet."@en ;
  schema:url <https://onco.cc/drugs/avantect-mcd/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/s42003-025-09017-4>, <https://doi.org/10.1016/j.jmoldx.2024.06.007>, <https://prevention.cancer.gov/news-and-events/news/nci-selects-two-assays-vanguard-study-multi-cancer-detection-tests>, <https://www.clearnotehealth.com/>, <https://clinicaltrials.gov/study/NCT06995898> ;
  onco:status "emerging" ;
  onco:tag "test", "mced", "evidence:insufficient" ;
  onco:modality "Multi-cancer early detection blood test (cell-free DNA 5-hydroxymethylcytosine)" ;
  onco:related <https://onco.cc/drugs/shield-mcd/> ;
  onco:technologies <https://onco.cc/technologies/mced/>, <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/technologies/methylation-profiling/> ;
  onco:companies <https://onco.cc/companies/clearnote-health/> ;
  onco:trials <https://onco.cc/trials/vanguard-study/>, <https://onco.cc/trials/clearnote-multi-cancer-epigenomics/>, <https://onco.cc/trials/inova-burn-pit-screening/> .